Affordable Access

Rationale and design of the enoximone clinical trials program.

Authors
Type
Published Article
Journal
Journal of Cardiac Failure
1071-9164
Publisher
Elsevier
Publication Date
Volume
11
Issue
9
Pages
659–669
Identifiers
PMID: 16360960
Source
Medline
License
Unknown

Abstract

These studies are Phase III, multicenter, randomized, double-blinded, placebo-controlled trials designed to test the general hypothesis that chronic oral administration of low doses of enoximone can produce beneficial effects in subjects with advanced or ultra-advanced chronic heart failure.

Statistics

Seen <100 times